Cheplapharm Arzneimittel is a pharmaceutical service provider, mainly providing users with branded drugs, medical products, supplements and cosmetics. Recently, Cheplapharm Arzneimittel received a strategic investment of 550 million euros, GIC Singapore Government Investment Corporation and Atlantic Park invested.
This article is reproduced from: https://www.itjuzi.com/investevent/13624613
This site is for inclusion only, and the copyright belongs to the original author.